Abstract
A REVIEW ON CARDIAC HYPERTROPHY & TREATMENT STRATEGY

Rahul Jaiswal*, Dr. Amit Kishor Srivastava, Gulab Chandra, Dr. Rohit Mohan, Dr. Amresh Gupta and Rupali Jaiswal

ABSTRACT

The heart is capable of answering to stressful situations by extending muscle mass, which is broadly defined as cardiac hypertrophy. This process decreases ventricular wall stress for the heart undergoing a greater than normal workload. In starting stage, cardiac hypertrophy is associated with normal or increased cardiac function and is considered to be adaptive or physiological; while, at later stages, if the stimulus is not removed, it is affiliated with contractile dysfunction and is termed pathological cardiac hypertrophy. The exercise-induced extend in the capacity of pumping blood leads to thickening of the ventricle wall, insinuated as physiological hypertrophy, while the reduced capacity of pumping blood as a result of hypertension and volume overload on the heart indicates pathological hypertrophy. The prevention master plan for cardiac hypertrophy involves both surgically and medicinally like thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin (Ang) II receptor blockers, beta-blockers, and calcium channel blockers. In this review, we focus on significant knowledge regarding cardiac hypertrophy and current emerging approaches to forbid hypertrophy with the ultimate goal to prevent or delay the onset of heart failure and sudden death in patients.

Keywords: Cardiac hypertrophy, Physiological cardiac hypertrophy, Pathological cardiac hypertrophy, Treatment.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • EJBPS: JULY ISSUE PUBLISHED

    JULY 2021 Issue has been successfully launched on 1 July 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT